News
Stockhead on MSN40m
ASX Quarterly Health Wrap: Island completes Phase 2a/b mosquito-borne dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback